1. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis.
   Jung-Soo Pyo et al, 2016, Int J Biol Markers CrossRef
2. Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers
   Safinur Atay et al, 2018, Mol Cell Proteomics CrossRef
3. Prognostic impact of preoperative neutrophil–lymphocyte ratio for surgically resected gastrointestinal stromal tumors
   Jing Yang et al, 2019, Medicine CrossRef
4. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo
   Guan Jiang et al, 2015, J Cancer Res Clin Oncol CrossRef
5. Cytotoxic Effects of Intranasal Midazolam on Nasal Mucosal Tissue
   I Ozbay et al, 2015, Journal of Craniofacial Surgery CrossRef
6. Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures
   LORENZ KADLETZ et al, 2015 CrossRef
7. Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors
   Nurten Turkel Kucukmetin et al, 2015, European Journal of Gastroenterology & Hepatology CrossRef
8. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors
   Fan Feng et al, 2016, Medicine CrossRef
9. Epigenetic Regulation of CD133 in Gastrointestinal Stromal Tumors.
   Helene Geddert et al, 2017, Am J Clin Pathol CrossRef
10. Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors
    Yu Zhou et al, 2017, Medicine CrossRef
11. Surgical Pathology of Gastrointestinal Stromal Tumors
    Gregory W. Charville et al, 2017, Advances In Anatomic Pathology CrossRef
12. Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort
    Qing-Wei Zhang et al, 2020, Clin Trans Med CrossRef
13. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67
    Asmaa G. Abdou et al, 2021 CrossRef
14. Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GIST
    Hao Xu et al, 2018, Mol Cancer Ther CrossRef
15. Development and validation of a nomogram to predict Ki67 expression in hepatocellular carcinoma based on preoperative contrast-enhanced CT features and clinical factors
    Tengfei Song et al, 2024, Chin J Acad Radiol CrossRef